Preview

Obstetrics, Gynecology and Reproduction

Advanced search

Stillbirth and fetal growth restriction

https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.357

Abstract

Aim: to estimate the rate of early-onset and late-onset fetal growth restriction (FGR) in stillbirth, identify features of placentaassociated complications and determine respective risk factors of stillbirth (especially at early gestational age).

Materials and Methods. There were retrospectively studied 61 stillbirth cases in 2016–2019 that occurred in the III level obstetric hospitals: 32 early (23–31 weeks of gestation) and late (32–39 weeks) cases; 156 live births with 8–10 Apgar scores delivered at 36–41 weeks of gestation used as controls. Quantitative parameters were compared using the mean values and standard deviation; nominal parameters were analyzed using odds ratio (OR) and adjusted OR (aOR) with 95 % confidence interval (CI).

Results. More than half of stillbirths are associated with FGR with almost 60 % of early-onset phenotype of this pathology. Both in stillbirths and live births, 2/3 of FGR have extremely low weight (OR = 1.8; 95 % CI = 0.6–6.9); 1/3 of growth restricted fetuses were detected shortly before delivery (OR = 1.3; 95 % CI = 0.7–2.4); 1/4 of pregnancies complicated by placental insufficiency are not associated with FGR (OR = 1.4; 95 % CI = 0.7–2.7). Risk factors of stillbirth in pregnancy complicated by FGR are the early-onset growth restriction phenotype (aOR = 3.2; 95 % CI = 1.0–10.3), maternal age over 28 years (aOR = 6.0; 95 % CI = 1.2–29.4), miscarriages and multiple induced abortions (aOR = 3.6; 95 % CI = 1.1–11.2), non-compliance in regular clinics visiting and correction of threatening conditions (aOR = 10.9; 95 % CI = 1.3–91.6), toxoplasma infection (aOR = 6.0; 95 % CI = 1.5–24.5). Early stillbirth with FGR is associated with an older mother's age (aOR = 5.8; 95 % CI = 1.0–34.4), greater parity (aOR = 3.3; 95 % CI = 1.0–10.4), uterine diseases including endometrial polyps, endometriosis, cervix cervicitis, cervix dysplasia (aOR = 4.0; 95 % CI = 0.9–17.2), diabetes mellitus (aOR = 3.1; 95 % CI = 0.8–13.2) and preeclampsia.

Conclusion. The rate of early-onset FGR in stillbirth comprises almost 60 % that is twice higher than in live birth, with the rate of late-onset phenotype being less than 30 %. In late stillbirths the early-onset phenotype also prevails. There are no prominent features for stillbirths with FGR compared to previously known risk factors regardless of hypotrophy. Early vs. late stillbirth with FGR is more associated with gynecological pathologies as well as with diabetes mellitus and preeclampsia.

About the Authors

V. G. Volkov
Tula State University, Medical Institute
Russian Federation

Valerii G. Volkov – MD, Dr Sci Med, Professor, Head of the Department of Obstetrics and Gynecology

128 Boldina Str., Tula 300028



M. V. Kastor
Tula State University, Medical Institute; Gumilevskaya Tula Regional Perinatal Center
Russian Federation

Margarita V. Kastor – Postgraduate Student, Obstetrics and Gynecology Department

128 Boldina Str., Tula 300028

1D Vilyamsa Str., Tula 300053



References

1. Degtyareva E.A., Zakharova O.A., Kufa M.A. et al. The efficacy of prognosis and early diagnostics of fetal growth retardation. [Effektivnost' prognozirovaniya i rannej diagnostiki zaderzhki rosta ploda]. Rossijskij vestnik perinatologii i pediatrii. 2018;63(6):37–45. (In Russ.). https://doi. org/10.21508/1027-4065-2018-63-5-37-45.

2. Kuklina L.V., Kravchenko E.N., Krivchik G.V. The role of the infectious factor in the formation of fetal growth retardation and gestation outcomes. [Rol’ infektsionnogo faktora v formirovanii zaderzhki rosta ploda i iskhody gestatsii]. Mat’ i Ditya v Kuzbasse. 2020;81(2):20–25. (In Russ.). https://doi.org/10.24411/2686-7338-2020-10017.

3. Flenady V., Ellwood D. Making real progress with stillbirth prevention. Aust New Zeal J Obstet Gynaecol. 2020;60(4):495–7. https://doi.org/10.1111/AJO.13208.

4. Beznoshchenko G.B., Kravchenko E.N., Kuklina L.V. et al. Fetal growth retardation: risk factors and prognosis. [Zaderzhka rosta ploda: faktory riska i prognozirovanie]. Tavricheskij mediko-biologicheskij vestnik. 2016;19(2):18–21. (In Russ.).

5. Vorontsova Z.A., Zhilyaeva O.D., Zolotareva S.N., Logacheva V.V. Experimental modeling of placental insufficiency and fetal growth retardation syndrome (literature review). [Eksperimental'noe modelirovanie placentarnoj nedostatochnosti i sindroma zaderzhki rosta ploda (obzor literatury)]. Vestnik novyh medicinskih tekhnologij. Elektronnoe izdanie. 2021;15(1):35–46. (In Russ.). https://doi.org/10.24412/2075-4094-2021-1-1-5.

6. Strizhakov A.N., Ignatko I.V., Timokhina E.V., Kardanova M.A. Critical fetal status: diagnostic criteria, obstetric tactics, perinatal outcomes. [Kriticheskoe sostoyanie ploda: diagnosticheskie kriterii, akusherskaya taktika, perinatal'nye iskhody]. Moscow: GEOTAR-Media, 2019. 173 p. (In Russ.). Available at: https://akusher-lib.ru/wp-content/uploads/2020/08/ Kriticheskoe-sostoyanie-ploda.pdf. [Aссessed: 15.09.2022].

7. Ego A., Monier I., Skaare K., Zeitlin J. Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case–control study. Ultrasound Obstet Gynecol. 2020;55(5):613–20. https://doi.org/10.1002/ UOG.20414.

8. Kastor M.V. Assessment of medical and social risk factors of stillbirth depends on gestational age: a retrospective study. [Ocenka medikosocial'nyh faktorov riska mertvorozhdeniya v zavisimosti ot sroka gestacii: retrospektivnoe issledovanie]. Vestnik novyh medicinskih tekhnologij. Elektronnoe izdanie. 2021;15(3):28–34. (In Russ.). https://doi. org/10.24412/2075-4094-2021-3-1-4.

9. Page J.M., Blue N.R., Silver R.M. Fetal growth and stillbirth. Obstet Gynecol Clin North Am. 2021;48(2):297–310. https://doi.org/10.1016/J. OGC.2021.03.001.

10. Volkov V.G., Kastor M.V. Modern view on classification and determination of the causes of stillbirth. [Sovremennye vzglyady na problemu klassifikacii i opredeleniya prichin mertvorozhdeniya]. Rossijskij vestnik akushera-ginekologa. 2020;20(3):29–34. (In Russ.). https://doi. org/10.17116/ROSAKUSH20202003129.

11. Clinical guidelines – Insufficient fetal growth requiring the medical care for the mother (fetal growth retardation) – 2022-2023-2024 (14.02.2022). [Klinicheskie rekomendacii – Nedostatochnyj rost ploda, trebuyushchij predostavleniya medicinskoj pomoshchi materi (zaderzhka rosta ploda) – 2022-2023-2024 (14.02.2022)]. Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2022. 47 p. (In Russ.). Available at: http://disuria.ru/_ld/11/1152_kr22O36p5MZ.pdf. [Aссessed: 15.09.2022].

12. Lees C.C., Stampalija T., Baschat A. et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. 2020;56(2):298–312. https://doi.org/10.1002/UOG.22134.

13. Dobrokhotova Yu.E., Dzhokhadze L.S., Kuznetsov P.A., Kozlov P.V. Placental insufficiency. Modern look. [Placentarnaya nedostatochnost'. Sovremennyj vzglyad]. Moscow: GEOTAR-Media, 2019. 18 p. (In Russ.). Available at: https://medknigaservis.ru/wp-content/uploads/2019/01/ NF0013295.pdf. [Aссessed: 15.09.2022].

14. Lomova N.A., Ganichkina M.B., Khachaturyan A.A. et al. Molecular genetic predictors of congenital infection in fetal growth restriction pregnancy. [Molekulyarno-geneticheskiye prediktory vrozhdennoy infektsii pri zaderzhke rosta ploda]. Medical Council. 2016;(17):156–159. (In Russ.). https://doi.org/10.21518/2079-701X-2016-17-156-159.

15. Makarov I.O., Yudina E.V. Cardiotocography during pregnancy and childbirth: a tutorial. [Kardiotokografiya pri beremennosti i v rodakh: uchebnoye posobiye]. Moscow: MEDpress-inform, 2016. 116 p. (In Russ.). Available at: https://contmed.ru/upload/books/pdf/62a19fbb911 22d4ac1b3238142021a20.pdf. [Aссessed: 15.09.2022].

16. Papastefanou I., Nowacka U., Syngelaki A. et al. Competing-risks model for prediction of small-for-gestational-age neonate from estimated fetal weight at 19–24 weeks’ gestation. Ultrasound Obstet Gynecol. 2021;57(6):917–24. https://doi.org/10.1002/UOG.23593.

17. Demirci O., Selçuk S., Kumru P. et al. Maternal and fetal risk factors affecting perinatal mortality in early and late fetal growth restriction. Taiwan J Obstet Gynecol. 2015;54(6):700–4. https://doi.org/10.1016/J. TJOG.2015.03.006.

18. Order of the Ministry of Health and Social Development of Russia dated of December 27, 2011 No. 1687n “On medical criteria for birth, the form of a birth document and the procedure for issuing it” (with amendments and additions; revised on 13.09.2019). [Prikaz Minzdravsocrazvitiya Rossii ot 27.12.2011 № 1687n «O medicinskih kriteriyah rozhdeniya, forme dokumenta o rozhdenii i poryadke ee vydachi» (s izmeneniyami i dopolneniyami; red. ot 13.09.2019)]. (In Russ.). Available at: http:// publication.pravo.gov.ru/Document/View/0001201910220042. [Aссessed: 15.09.2022].

19. Gardosi J., Francis A., Turner S., Williams M. Customized growth charts: rationale, validation and clinical benefits. Am J Obstet Gynecol. 2018;218(2S):S609–S618. https://doi.org/10.1016/J.AJOG.2017.12.011.

20. Centile Calculator. Gestation Network. Available at: https://www.gestation. net/cc/about.htm. [Aссessed: 15.09.2022].

21. Goryunova A.G., Simonova M.S., Murashko A.V. Fetal growth retardation syndrome and adaptation of the placenta. [Sindrom zaderzhki rosta ploda i adaptaciya placenty]. Arhiv akusherstva i ginekologii imeni V.F. Snegireva. 2016;3(2):76–80. (In Russ.). https://doi. org/10.18821/2313-8726-2016-3-2-76-80.

22. Aziz A., Tiwari S., Dey M., Singh S. Maternal and fetal factors associated with non detection of fetal growth restriction at term: a retrospective study. Int J Reprod Contraception, Obstet Gynecol. 2020;9(10):4164–8. https://doi.org/10.18203/2320-1770.IJRCOG20204307.

23. Brackett E.E., Hall E.S., Defranco E.A., Rossi R.M. Factors associated with occurrence of stillbirth before 32 weeks of gestation in a contemporary cohort. Am J Perinatol. 2022;39(1):84–91. https://doi. org/10.1055/S-0040-1714421.

24. Zile I., Ebela I., Rumba-Rozenfelde I. Maternal risk factors for stillbirth: A registry-based study. Medicina (Kaunas). 2019;55(7):326. https://doi. org/10.3390/MEDICINA55070326.

25. Mecacci F., Serena C., Avagliano L. et al. Stillbirths at term: case control study of risk factors, growth status and placental histology. PLoS One. 2016;11(12):e0166514. https://doi.org/10.1371/JOURNAL. PONE.0166514.

26. Bring H.S., Varli I.A.H., Kublickas M. et al. Causes of stillbirth at different gestational ages in singleton pregnancies. Acta Obstet Gynecol Scand. 2014;93(1):86–92. https://doi.org/10.1111/AOGS.12278.

27. Hoyert D.L., Gregory E.C.W. Cause-of-death data from the Fetal Death File, 2015–2017. Natl Vital Stat Reports. 2020;69(4):1–20. Available at: https://pubmed.ncbi.nlm.nih.gov/32510316. [Aссessed: 15.09.2022].

28. Zhu J., Zhang J., Xia H. et al. Stillbirths in China: a nationwide survey. BJOG An Int J Obstet Gynaecol. 2021;128(1):67–76. https://doi.org/10.1111/1471-0528.16458.

29. Madhi S.A., Briner C., Maswime S. et al. Causes of stillbirths among women from South Africa: a prospective, observational study. Lancet Glob Heal. 2019;7(4):e503–e512. https://doi.org/10.1016/S2214- 109X(18)30541-2.

30. Makatsariya A.D., Bitsadze V.O., Khizroeva J.Kh., Khamani I.V. Placental insufficiency in complicated pregnancy and possibility of treatment with dipyridamole. [Platsentarnaya nedostatochnost’ pri oslozhnennoy beremennosti i vozmozhnosti primeneniya dipiridamola]. Obstetrics, Gynecology and Reproduction. 2016;10(4):72–82. (In Russ.). https://doi.org/10.17749/2313-7347.2016.10.4.072-082.

31. Klycheva O.I., Khuraseva A.B. Possibilities for predicting the risk of developing fetal growth retardation syndrome. [Vozmozhnosti prognozirovaniya stepeni riska razvitiya sindroma zaderzhki rosta ploda]. Rossijskij vestnik akushera-ginekologa. 2020;20(5):68–73. (In Russ.). https://doi.org/10.17116/ROSAKUSH20202005168.

32. Ashoor G., Syngelaki A., Papastefanou I. et al. Development and validation of model for prediction of placental dysfunction-related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid-gestation. Ultrasound Obstet Gynecol. 2022;59(1):61–8. https://doi.org/10.1002/ UOG.24795.

33. Chereshnev V.A., Pichugova S.V., Tulakina L.G. et al. Ultrastructure of placenta in antenatal fetal death. [Harakteristika ul'trastruktury placenty pri antenatal'noj gibeli ploda]. Obstetrics, Gynecology and Reproduction. 2018;12(3):36–46. (In Russ.) https://doi.org/10.17749/2313- 7347.2018.12.3.036-046.

34. Orudzhova E.A., Samburova N.V., Anichkova E.V. et al. Thrombophilia in the pathogenesis of fetal growth retardation. [Trombofilii v patogeneze zaderzhki rosta ploda]. Obstetrics, Gynecology and Reproduction. 2021;15(2):189–200. (In Russ.). https://doi.org/10.17749/2313-7347/ OB.GYN.REP.2021.223.

35. Dolgova Yu.S., Eremeeva D.R., Zainulina M.S. Risks of reproductive loss and placenta-mediated pregnancy complications in women with antiphospholipid antibodies. [Riski reproduktivnykh poter’ i platsentaoposredovannykh oslozhneniy beremennosti u zhenshchin s nositel’stvom antifosfolipidnykh antitel]. Obstetrics, Gynecology and Reproduction. 2020;14(6):592–601. (In Russ.). https://doi.org/10.17749/2313-7347/ ob.gyn.rep.2020.181.

36. Pestrikova T.Yu., Yurasova E.A., Tkachenko V.A. Placental insufficiency as the underlying condition of the complications and outcomes of the gestation period. [Placentarnaya nedostatochnost' kak bazovaya patologiya oslozhnenij i iskhodov gestacionnogo perioda]. Rossijskij vestnik akushera-ginekologa. 2020;20(1):5–15. (In Russ.). https://doi. org/10.17116/ROSAKUSH202020011.

37. Karelina O.B., Artymuk N.V. Stillbirth in the Kemerovo region: main causes, risk factors, problems of medical care. [Mertvorozhdayemost’ v Kemerovskoy oblasti: osnovnyye prichiny, faktory riska, problemy okazaniya pomoshchi]. Zhenskoye zdorov’ye i reproduktsiya. 2019;(2):32–9. (In Russ.).

38. Donnikov A.E., Vitvitskaya Yu.G., Kan N.E. et al. Diagnosis of infections in obstetric-gynecological and neonatological practice: Textbook. [Diagnostika infektsiy v akushersko-ginekologicheskoy i neonatologicheskoy praktike: Uchebnoye posobiye]. OOO «CPU RADUGA», 2018. 124 c. (In Russ.). Available at: https://www.dna-technology.ru/sites/default/files/diagnostika_ infekciy.pdf. [Aссessed: 15.09.2022].

39. Nayeri T., Sarvi S., Moosazadeh M. et al. The global seroprevalence of anti-Toxoplasma gondii antibodies in women who had spontaneous abortion: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2020;14(3):e0008103. https://doi.org/10.1371/JOURNAL.PNTD.0008103.

40. Perederyaeva E.B., Pshenichnikova T.B., Andreeva M.D., Makatsariya A.D. The pathogenetic mechanisms of development of preeclampsia in women with metabolic syndrome. [Patogeneticheskiye mekhanizmy razvitiya preeklampsii u zhenshchin s metabolicheskim sindromom]. Obstetrics, Gynecology and Reproduction. 2016;9(3):54–65. (In Russ.). https://doi. org/10.17749/2070-4968.2015.9.3.054-065.

41. Ronenson A.M. Two phenotypes of preeclampsia and two treatment strategies. [Dva fenotipa preeklampsii – dve strategii lecheniya]. Vestnik akusherskoj anesteziologii. 2021;(7):4–12. (In Russ.). Available at: https:// www.arfpoint.ru/wp-content/uploads/2021/07/vestnik-ijul.pdf. [Aссessed: 15.09.2022].


Review

For citations:


Volkov V.G., Kastor M.V. Stillbirth and fetal growth restriction. Obstetrics, Gynecology and Reproduction. 2023;17(1):104-114. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.357

Views: 604


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)